Serum ghrelin, adipokine and insulin levels in children with acute hepatitis

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 7, 2009, Pages 739-743

  Tóth, Gergely ^a,c   Rauh, Manfred ^b   Nyul, Zoltán ^a   Sulyok, Endre ^a   Rascher, Wolfgang ^b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c Hungarian Academy of Sciences   (Hungary)

Author keywords

Adipokine; Childhood; Ghrelin; Hepatitis

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GHRELIN; INSULIN; LEPTIN; RESISTIN;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EPSTEIN BARR VIRUS; FEMALE; FOOD INTAKE; HEPATITIS A VIRUS; HORMONE DETERMINATION; HUMAN; INSULIN BLOOD LEVEL; LIVER FUNCTION TEST; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; VIRUS HEPATITIS;

ACUTE DISEASE; ADIPOKINES; ADOLESCENT; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FASTING; FEMALE; GHRELIN; HEPATITIS A; HEPATITIS, VIRAL, HUMAN; HUMANS; LEPTIN; MALE; RESISTIN;

EID: 67651028334     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32830dfcca     Document Type: Article

References (48)

1. Frühbeck G, Gomez-Ambrosi J, Muruzabal FJ, Burrell MA. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 2001; 280:827-847. (Pubitemid 32553225)
2. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000; 106:473-481.
3. Sethi JK, Hotamisligil GS. The role of TNFα in adipocyte metabolism. Semin Cell Dev Biol 1999; 10:19-29.
4. Holst D, Grimaldi PA. New factors in the regulation of adipose differentiation and metabolism. Curr Opin Lipidol 2002; 13:241-245. (Pubitemid 34592279)
5. Rajala MW, Scherer PE. Minireview: the adipocyte at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003; 144:3765-3773.
6. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, et al. A role for ghrelin in the central regulation of feeding. Nature 2001; 409:194-198. (Pubitemid 32144284)
7. Shintani M, Ogawa Y, Ebihara K, Aizawa-abe M, Miyanaga F, Takaya K, et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001; 50:227-232. (Pubitemid 32127276)
8. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000; 407:908-913.
9. Wren AM, Small CJ,Ward HL, Murphy KG, Dakin CL, Taheri S, et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000; 141:4325-4328. (Pubitemid 30953551)
10. Ukkola O. Endocrinological activities of ghrelin: new insights. Eur J Intern Med 2003; 14:351-356. (Pubitemid 40090258)
11. Beltowski J. Adiponectin and resistin: new hormones of white adipose tissue. Med Sci Monit 2003; 9:55-61. (Pubitemid 36330378)
12. Chinetti G, Zawadski C, Fruchart JC, Staels B. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPAR, PPAR and LXR. Biochem Biophys Res Commun 2004; 314:151-158.
13. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 2004; 15:630-635. (Pubitemid 39221142)
14. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules. Adipocyte derived plasma protein adiponectin. Circulation 1999; 100:2473-2476.
15. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-B signaling through a cAMP-dependent pathway. Circulation 2000; 102:1296-1301. (Pubitemid 30728130)
16. Rakatzi I, Mueller H, Ritzeler O, Tennagels N, Eckel J. Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic-cell line INS-1. Diabetologia 2004; 47:249-258. (Pubitemid 38315361)
17. Lin LY, Lin CY, Su TC, Liau CS. Angiotensin II-induced apoptosis in human endothelial cells is inhibited by adiponectin through restoration of the association between endothelial nitric oxide synthase and heat shock protein 90. FEBS Lett 2004; 574:106-110.
18. Kobayashi H, Ouchi N, Kihara S,Walsh K, Kumada M, Abe Y, et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 2004; 94:27-31.
19. Masaki T, Chiba S, Tatsukawa T, Noguchi H, Seike M, Yoshimatsu H. Adiponectin protects LPS-induced liver injury through modulation of TNF-α in KK-Ay obese mice. Hepatology 2004; 40:177-184. (Pubitemid 38868936)
20. Xu A, Wang Y, Keshaw H, Xu LY, Lam KSL, Cooper GJS. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 2003; 112:91-100. (Pubitemid 38056380)
21. Kamada Y, Tamura S, Kiso S, Matsumoto H, Saji Y, Yoshida Y, et al. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 2003; 125:1796-1807. (Pubitemid 37500444)
22. Friedman JM, Halas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395:763-770. (Pubitemid 28485436)
23. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes 1996; 45:1455-1462.
24. Friedman JM. Leptin, leptin receptors and the control of body weight. Eur J Med Res 1997; 2:7-13.
25. Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, et al. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 1997; 82:1293-1300. (Pubitemid 27166679)
26. Bouret SG, Draper SJ, Simerly RB. Formation of projection pathways from the arcuate nucleus of the hypothalamus to hypothalamic regions implicated in the neural control of feeding behavior in mice. J Neurosci 2004; 24:2797-2805.
27. Ahima RS, Osei SY. Leptin signaling. Physiol Behav 2004; 81:223-241.
28. Faggioni R, Feingold KR, Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J 2001; 15:2565-2571. (Pubitemid 33131083)
29. Aleffi S, Petrai I, Bertolani C, Parola M, Colombatto S, Novo E, et al. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology 2005; 42:1339-1348. (Pubitemid 43260036)
30. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, et al. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 2000; 19:4046-4055. (Pubitemid 30608543)
31. Kim KH, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001; 276:11252-11256. (Pubitemid 38089312)
32. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR,Wright CM, et al. The hormone resistin links obesity to diabetes. Nature 2001; 409:307-312. (Pubitemid 32151228)
33. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89:2548-2556.
34. Steppan CM, Lazar MA. The current biology of resistin. J Intern Med 2004; 255:439-447.
35. Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 2004; 1:45. (Pubitemid 40412718)
36. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 2001; 50:2199-2202. (Pubitemid 33641901)
37. Rock CL, Coulstan AM, Ruffin MT. Diet therapy. In: Fauci AS, Braunwald E, Isselbacher KJ, editors. Harrison's principles of internal medicine. 14th ed. New York: McGraw-NewHil; 1998. pp. 465-472.
38. Onodera K, Kato A, Suzuki K. Serum leptin concentrations in liver cirrhosis: relationship to the severity of liver dysfunction and their characteristic diurnal profiles. Hepatol Res 2001; 21:205-212. (Pubitemid 33061718)
39. Tacke F, Brabant G, Kruck E, Horn R, Schöffski P, Hecker H, et al. Ghrelin in chronic liver disease. J Hepatol 2003; 38:447-454.
40. Marchesini G, Bianchi G, Lucidi P, Villanova N, Zoli M, De Feo P. Plasma ghrelin concentrations, food intake, and anorexia in liver failure. J Clin Endocrinol Metab 2004; 89:2136-2141. (Pubitemid 38619842)
41. Ataseven H, Halil Bahcecioglu I, Kuzu N, Yalniz M, Celebi S, Erensoy A, et al. The levels of ghrelin, leptin, TNF-a, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV Infection. Mediators Inflamm 2006; 4:78380. (Pubitemid 44182096)
42. Marchesini G, Pagotto U, Bugianesi E, De Iasio R, Manini R, Vanni E, et al. Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance. J Clin Endocrinol Metab 2003; 88:5674-5679. (Pubitemid 38033034)
43. Caner I, Selimoglu MA, Yazgi H, Ertekin V. Serum leptin levels in children with acute viral hepatitis A. West Indian Med J 2006; 55:409-413. (Pubitemid 46824627)
44. Tacke F, Wüstefeld T, Horn R, Luedde T, Srinivas Rao A, Manns MP, et al. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo. J Hepatol 2005; 42:666-673. (Pubitemid 40501683)
45. Tietge UJ, Böker KH, Manns MP, Bahr MJ. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. Am J Physiol Endocrinol Metab 2004; 287:82-89.
46. Wolf AM, Wolf D, Avila MA, Moschen AR, Berasain C, Enrich B, et al. Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice. J Hepatol 2006; 44:537-543. (Pubitemid 43227878)
47. Bahr MJ, Ockenga J, Böker KH, Manns MP, Tietge UJ. Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance. Am J Physiol Endocrinol Metab 2006; 291:199-206. (Pubitemid 44035277)
48. Breidert M, Zimmermann TF, Schneider R, Ehninger G, Brabant G. Ghrelin/leptin-imbalance in patients with primary biliary cirrhosis. Exp Clin Endocrinol Diabetes 2004; 112:123-126. (Pubitemid 38445490)